Jun112024Uncategorized Category: UncategorizedBy Charlotte Maddalena11 June 2024 Author: Charlotte Maddalena Post navigationPreviousPrevious post:ORPHELIA Pharma recrute un/une Chef de Projet Réglementaire SeniorNextNext post:Orphelia Pharma provides update on the regulatory submission of KIZFIZO® with the European Medicines AgencyRelated PostsOrphelia Pharma provides update on the regulatory submission of KIZFIZO® with the European Medicines Agency18 November 2024ORPHELIA Pharma recrute un/une Chef de Projet Réglementaire Senior7 June 2024ORPHELIA Pharma and University of Birmingham strengthen their collaboration to support the registration of KIZFIZO®22 May 2024Orphelia Pharma secures European patent covering KIGABEQ®, the first pediatric formulation of vigabatrin18 April 2024Six new projects supported by our Foundation18 March 2024Four houses for the FAOMA call for projects18 March 2024
Orphelia Pharma provides update on the regulatory submission of KIZFIZO® with the European Medicines Agency18 November 2024
ORPHELIA Pharma and University of Birmingham strengthen their collaboration to support the registration of KIZFIZO®22 May 2024
Orphelia Pharma secures European patent covering KIGABEQ®, the first pediatric formulation of vigabatrin18 April 2024
